Interventional Radiology, Radiation Technician, Laboratory Technician, Oncology Nursing. Merck Foundation through its Merck Foundation Cancer Access Program has provided 194 scholarships of Oncology ...

Quibim, a global company pioneering imaging biomarkers for precision medicine, announces that its prostate cancer lesion detection capability of its flagship QP-Prostate® CAD solution has received 510 ...

DelveInsight recently conducted an in-depth MASH Market Size and Share Assessment to help a pharmaceutical client understand the evolving Metabolic Dysfunction-Associated Steatohepatitis (MASH) market ...

Interventional Radiology, Radiation Technician, Laboratory Technician, Oncology Nursing. Merck Foundation through its Merck Foundation Cancer Access Program has provided 194 scholarships of Oncology ...

A glaring exception is immune-oncology house Viralytics, acquired by Merck of the US (MND ... on paper often don’t eventuate for valuation reasons. For instance, a radiology giant would love to own ...

In what’s shaping up to be a red-letter week for Gardasil, Merck & Co. has simultaneously opened a massive new manufacturing facility for the human papillomavirus (HPV) shot in the U.S. and put ...

Merck shares have been under pressure amid disappointing sales trends for its Gardasil HPV vaccine. The company's broader drug portfolio continues to perform well and is driving a strong earnings ...

Merck is bracing for the years of sales growth from oncology superstar Keytruda to take a sharp turn in 2028—and for more reasons than one. Along with a key U.S. patent expiring at the end of ...

Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S. manufacturing amid President Donald Trump's tariff threats. Trump ...

Merck (NYSE:MRK) said it expects its top-selling drug, Keytruda, to be selected by the U.S. government for price setting negotiations next year under the Inflation Reduction Act. In a filing with ...

Merck & Co.'s first trial over the safety of its blockbuster cancer vaccine Gardasil was postponed mid-trial due to concerns that jurors might be influenced by media coverage surrounding the ...